Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1985 Jul;45(7):3053-7.

Biological and biophysical properties of the tumor-localizing component of hematoporphyrin derivative

Biological and biophysical properties of the tumor-localizing component of hematoporphyrin derivative

D Kessel et al. Cancer Res. 1985 Jul.

Abstract

Reverse-phase chromatography, aqueous gel exclusion, and nonaqueous gel exclusion were assessed as procedures for preparative fractionation of the tumor-localizing product hematoporphyrin derivative. Porphyrin accumulation, fluorescence, and photodynamic cytotoxicity were monitored using the murine Sarcoma 180 tumor. Aqueous gel exclusion chromatography can provide a hematoporphyrin derivative fraction enriched in the tumor-localizing component. A further enrichment occurs when this procedure is carried out at 55 degrees C, but nonlocalizing porphyrins could not be eliminated. While providing a better separation, reverse-phase chromatography cannot provide a tumor-localizing fraction free from contaminating protoporphyrin. However, this and other contaminants can be eliminated from the tumor-localizing fraction via nonaqueous gel exclusion chromatography. This latter separation provides two tumor-localizing products: a fast-eluting fraction enriched in the major photosensitizing component(s); and a more complex slowly eluting fraction enriched in fluorescence localizers.

PubMed Disclaimer

Figures

Chart 1
Chart 1
Reverse-phase HPLC analysis of HPD.
Chart 2
Chart 2
HPLC analysis of the first-eluted HPD fractions from a P-10 column. A, solvent, water at 20°C; B, solvent, water at 55°C; C, solvent, formamide:water (1:1) at 20°C.
Chart 3
Chart 3
Preparative fractionation of HPD on an LH-20 column. Absorbance at 500 nm was monitored; specified fractions were pooled for HPLC analysis.
Chart 4
Chart 4
HPLC analysis of pooled HPD fractions eluted from an LH-20 column (Chart 3). A, Fractions 1 to 3; B, Fractions 4 and 5; C, Fractions 6 to 10.
Chart 5
Chart 5
Relative elution volume versus molecular weight of a series of dyes on an analytical LH-20 column. 1, neutral red; 2, methylene blue; 3, phenol red; 4, merocyanine 530; 5, hematoporphyrin; 6, eosin Y; 7, rose bengal; 8, Fraction B (Chart 4); 9, Fraction A (Chart 4); 10, vitamin B12.
Chart 6
Chart 6
Degradation of Fraction A (Chart 4) when held at (left) 100°C for 100 min or (right) 4°C for 100 days.
Chart 7
Chart 7
Absorption patterns of 1-μg/ml porphyrin solutions in water, methanol (MeOH), or 10 mm aqueous CTAB. Left, Fraction A (Chart 4); right, HP. For the latter compound, the tracings in CTAB and methanol were identical.

References

    1. Dougherty TJ, Boyle DG, Weishaupt KR, Henderson BA, Potter WR, Bellnier DA, Wityk KE. Photoradiation therapy—clinical and drug advances. In: Kessel D, Dougherty TJ, editors. Porphyrin Photosensitization. Plenum Publishing Corp; New York: 1983. pp. 3–13. - PubMed
    1. Kessel D. Hematoporphyrin and HPD: photophysics, photochemistry and Phototherapy. Photochem. Photobiol. 1984;39:851–859. - PubMed
    1. Spikes J. Photodynamic reactions in photomedicine. In: Regan JD, Parrish JA, editors. The Science of Photomedicine. Plenum Publishing Corp; New York: 1983. pp. 113–144.
    1. Gomer CJ, Dougherty TJ. Determination of [3H]- and [14C]hematoporphyrin derivative distribution in malignant and normal tissue. Cancer Res. 1979;39:146–151. - PubMed
    1. Berenbaum MC, Bonnett R, Scourides PA. In vivo biological activity of the components of haematoporphyrin derivative. Br. J. Cancer. 1982;45:571–581. - PMC - PubMed

Publication types

LinkOut - more resources